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Phagocytosis controls CNS homeostasis by facili-
tating the removal of unwanted cellular debris.
Accordingly, impairments in different receptors or
proteins involved in phagocytosis result in enhanced
inflammation and neurodegeneration. While various
studies have identified extrinsic factors that modu-
late phagocytosis in health and disease, key intracel-
lular regulators are less understood. Here we show
that the autophagy protein beclin 1 is required for
efficient phagocytosis in vitro and in mouse brains.
Furthermore, we show that beclin 1-mediated
impairments in phagocytosis are associated with
dysfunctional recruitment of retromer to phagosomal
membranes, reduced retromer levels, and impaired
recycling of phagocytic receptors CD36 and Trem2.
Interestingly, microglia isolated from human Alz-
heimer’s disease (AD) brains show significantly
reduced beclin 1 and retromer protein levels. These
findings position beclin 1 as a link between auto-
phagy, retromer trafficking, and receptor-mediated
phagocytosis and provide insight into mechanisms
by which phagocytosis is regulated and how it may
become impaired in AD.
INTRODUCTION
Microglia are the immune cells of the brain. They constantly sur-
vey the brain for abnormalities and are quickly activated upon
encountering tissue damage or injury (Nimmerjahn et al., 2005).
Following activation, microglia become capable of numerous
functions depending on the stimuli in the surrounding environ-ment. One such function is phagocytosis, which facilitates brain
homeostasis via the clearance of cellular debris and possibly the
pruning of synapses (Lucin and Wyss-Coray, 2009; Nimmerjahn
et al., 2005; Paolicelli et al., 2011). In addition to general mainte-
nance roles, recent genome-wide association studies also sug-
gest that microglial phagocytic receptors may have a critical
role in Alzheimer’s disease (AD). Indeed, rare variants of the
phagocytic receptor TREM2 triple the risk of developing AD
and represent one of the strongest known risk factors (Guerreiro
et al., 2013; Jonsson et al., 2013). In mice, genetic defects in
different receptors or proteins involved in phagocytosis result
in neurodegeneration (Kaifu et al., 2003; Lu et al., 1999; Lu and
Lemke, 2001) and may be responsible for increased amyloidosis
in mouse models of AD (Wyss-Coray et al., 2002). Conversely,
driving microglial activation toward a more phagocytic pheno-
type reduces Ab pathology in mouse models of AD (Heneka
et al., 2013). These studies highlight the importance of phagocy-
tosis in brain homeostasis and suggest that identifying key reg-
ulators of phagocytosis may represent a therapeutic target for
the treatment of neurological disease. While various studies
have identified extrinsic factors that modulate phagocytosis in
health and disease (Lucin and Wyss-Coray, 2009), key intracel-
lular regulators are much less understood.
Beclin 1 represents an intriguing target that may act to regulate
phagocytic receptor function in health and disease. Indeed, be-
clin 1 is actively involved in protein degradation and host defense
and, in mouse models of Alzheimer’s and Parkinson’s disease,
has a critical role in mitigating amyloidosis and neurodegenera-
tion (Levine et al., 2011; Pickford et al., 2008; Spencer et al.,
2009). While beclin 1 is classically associated with autophagy,
a major protein degradation pathway, studies now suggest
that beclin 1 may also have alternative functions independent
of autophagy. This is suggested by studies showing that genetic
deletion of beclin 1 results in lethality at embryonic day 7.5–8.5
(Qu et al., 2003; Yue et al., 2003), while genetic deletion of
various downstream autophagy proteins results in postnatalNeuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc. 873
Figure 1. Reduced Beclin 1 Impairs Micro-
glial Phagocytosis
(A) BV2microglia cells were infected with lentivirus
encoding for luciferase shRNA (control) or beclin 1
shRNA (KD). Cell lysates were analyzed by west-
ern blot.
(B and C) Infected cells were provided fluorescent
latex beads and phagocytosis was analyzed by
flow cytometry. Data are expressed as phagocytic
index, which is the percent of cells that phagocy-
tose beads.
(D) BV2 cells receiving beclin 1 shRNA lentivirus
were transduced with lentivirus encoding for
mouse beclin 1 (mBeclin 1), and cell lysates were
analyzed by western blot.
(E) Recovering beclin 1 levels was sufficient to
improve phagocytosis of latex beads. Results
were compared by an unpaired Student’s t test (C)
or a one-way ANOVA with a Tukey’s post test (E)
and are representative of at least three indepen-
dent experiments (n = 3 per group). Values are
mean ± SEM. ***p < 0.001.
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Beclin 1 Regulates Phagocytic Efficiencylethality (Komatsu et al., 2005; Kuma et al., 2004). What these
additional functions of beclin 1 might be is not entirely clear.
However, given that apoptotic cell clearance is impaired during
mouse embryonic development when beclin 1 is knocked out
(Qu et al., 2007), one possibility is a role in clearance processes
such as phagocytosis. To that end, recent studies reveal that
beclin 1 rapidly associates with phagosomes (Berger et al.,
2010; Sanjuan et al., 2007) and receptor complexes at the cell
surface (Berger et al., 2010; Yue et al., 2002) in the absence of
autophagosomes. Whether beclin 1 has an essential role in
receptor-mediated phagocytosis is unknown. Furthermore,
whether microglial beclin 1 is dysfunctional during neurological
disease and how this dysfunction may impair phagocytosis of
disease-relevant substrates also remains unexplored.
Here, we identify a role for microglial beclin 1 in receptor-medi-
ated phagocytosis. Beclin 1, together with its phosphatidylinosi-
tol 3-kinase (PI3K) binding partner, Vps34, accomplish this by
regulating the retromer complex, which is involved in sorting
cellular components to the lysosome or recycling the compo-
nents back to defined compartments (e.g., the cell surface).
Consequently, genetic reduction of beclin 1 results in reduced
retromer levels, phagocytic receptor recycling, and phagocy-
tosis of latex beads and Ab. Importantly, beclin 1 and retromer
are reduced in microglia isolated from postmortem human AD
brains. Together these findings suggest that similar mechanisms
may be impaired in AD, possibly rendering microglia less effi-
cient at phagocytosing Ab or any other potentially toxic debris
whose uptake depends on receptor-mediated phagocytosis.
RESULTS
Reduced Beclin 1 Impairs Phagocytosis
To determine whether beclin 1 has a role in phagocytosis, we
reduced its expression in BV2 microglial cells with lentivirus874 Neuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc.encoding beclin 1 shRNA (beclin 1 knockdown; KD) and
assayed for microglial uptake of latex beads. Using this lentivi-
ral approach, which allowed us to reduce beclin 1 expression
by 80% (Figure 1A), we find that reducing microglial beclin
1 levels significantly impaired the phagocytosis of fluorescent
latex beads as determined by flow cytometry (Figures 1B
and 1C). This effect was not exclusive to BV2 cells as N9
cells, another mouse microglial cell line, and C6 astrocyte
cells showed a similar phagocytic defect when beclin 1 was
reduced (Figures S1A and S1B). Importantly, phagocytosis
was ‘‘rescued’’ in BV2 cells by recovering beclin 1 levels
with a lentivirus encoding mouse beclin 1 (Figures 1D and
1E), demonstrating the specificity of the beclin 1 shRNA
knockdown approach. Interestingly, reduced expression of
Atg5, a protein critical for autophagy downstream of beclin 1,
did not alter phagocytosis (Figures S1C and S1D), suggesting
that beclin 1 may regulate phagocytosis through alternative
pathways.
Along with changes in overall phagocytosis, flow cytometry
scattergrams also suggested that phagocytic efficiency was
impaired in beclin 1-deficient BV2 cells, as indicated by the
loss of highly phagocytic cell populations (Figure 1B). Subse-
quent flow cytometry analysis revealed that while significantly
more beclin 1-deficient cells phagocytosed a single bead, they
were less competent at phagocytosing 3–10 beads (Figure 2A)
when compared with control shRNA transduced BV2 cells.
Impaired phagocytic efficiency by beclin 1-deficient BV2 cells
could also be rescued by recovering beclin 1 levels (Figure 2B).
To confirm these findings in primary cells, we next isolated
microglia from beclin 1 heterozygous knockout mice (beclin
1+/) (Figure 2C), which show a 40%–50% reduction in beclin 1
levels (Pickford et al., 2008; Qu et al., 2003). In agreement with
our lentiviral approach, beclin 1+/microglia also showed impair-
ments in phagocytic efficiency when analyzed by flow cytometry
Figure 2. Reduced Beclin 1 Impairs Microglial Phagocytic Efficiency
(A–G) BV2microglia cells were infected with lentivirus encoding for luciferase shRNA (control) or beclin 1 shRNA (KD). (A) Phagocytosis of fluorescent latex beads
was assayed by flow cytometry, and analysis of flow cytometry histograms determined the number of BV2 cells phagocytosing relative quantities of beads. (B)
Recovering beclin 1 levels with a lentivirus encoding for mouse beclin 1 (mBeclin 1) was sufficient to rescue phagocytic efficiency asmeasured by flow cytometry.
(C) Primary microglia were isolated from beclin 1+/ (Becn1+/) or wild-type (WT) mice and labeled with fluorescently tagged antibodies against CD11b or isotype
control antibodies. The percent of CD11b+ cells in the microglial population was determined by flow cytometry relative to the cells receiving isotype control
antibody. The microglial population was determined to be 90% pure. (D) The average number of beads phagocytosed by Becn1+/ and WT primary microglia
was quantified by flow cytometry. (E) Using live-cell imaging, the number of beads phagocytosed over time wasmonitored. (F) Cell motility was alsomonitored by
live-cell imaging. (G) Shown are representative images from live-cell imaging at various times after the administration of beads. To better visualize the beads, an
outline is provided around each bead. Scale bar, 15 mm. For further analysis of bead uptake, please see Figure S2. Results were compared by a two-way ANOVA
with a Bonferroni post test (A and E), a one-way ANOVA with a Tukey’s post test (B), or an unpaired Student’s t test (D and F) and are representative of at least
three independent experiments (A and B, n = 3 per group; D, n = 4–6 per group; E and F, n = 10–16 per group). Values are mean ± SEM. *p < 0.05, **p < 0.01, ***p <
0.001; n.s., not significant.
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beclin 1-deficient cells resulted from beads stalling at the cell
surface or from a disruption in the kinetics of phagocytosis, we
used microscopy and live-cell imaging. We observed that while
beads were initially phagocytosed at a similar rate (Figure S2A),
beclin 1-deficient BV2 cells were less able to phagocytose sub-
sequent beads (Figure S2B and Figure 2E). Quantification of cell
migration confirmed that beclin 1-deficient cells have a similar
migratory capacity as control cells, indicating that impaired
movement is not responsible for phagocytic deficits (Figure 2F).
Instead, our data suggest that beclin 1 deficiency impairs the
ability of cells to phagocytose subsequent beads beyond the
initial phagocytic event (see Figure 2G for representative live-
cell images), resulting in overall reduced phagocytic uptake
(Figure S2C).
Reduced Beclin 1 Disrupts Retromer-Mediated
Recycling of Phagocytic Receptors
Phagocytosis is initiated by numerous receptors that recognize
molecular structures on extracellular substrates. Upon binding
and internalization of substrates, phagocytic receptors are re-
cycled back to the cell surface to be used again. Accordingly,
disruptions in phagocytic receptor recycling have dramatic con-
sequences on phagocytic efficiency (Chen et al., 2010). To deter-
mine if reduced phagocytic efficiency seen in beclin 1-deficientcells is due to changes in phagocytic receptor dynamics, we
used an established receptor recycling assay (Mitchell et al.,
2004) (Figure 3B). Indeed, beclin 1-deficient BV2 cells showed
a prominent reduction in recycling of the phagocytic receptor
CD36 (Figures 3C and 3D), a class B scavenger receptor
involved in phagocytosing a wide range of substrates, including
Ab (El Khoury et al., 2003) and latex beads (Figure 3A). Primary
microglia obtained from beclin 1+/ mice also showed a similar
deficit in CD36 recycling (Figures 3E and 3F). Importantly, flow
cytometric analysis demonstrated that beclin 1 shRNA did not
affect baseline cell surface expression of CD36 in the absence
of ligand (Figure 3G). Additionally, because the phagocytic
receptor Trem2 has been reported to recycle (Prada et al.,
2006) and is a risk factor for AD (Guerreiro et al., 2013; Jonsson
et al., 2013), we investigated Trem2 recycling in beclin 1-defi-
cient BV2 cells. Trem2 recycling was impaired in beclin 1-defi-
cient BV2 cells as was observed with CD36 (Figure 3H). Taken
together, these data suggest that beclin 1 has a function in
phagocytic receptor recycling.
Beclin 1 and Its Binding Partner, Vps34, Regulate
Retromer Localization
While receptor recycling is regulated by numerous mechanisms,
a recent study in C. elegans showed that clearance of apoptotic
cell corpses by the phagocytic receptor CED-1 was dependentNeuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc. 875
Figure 3. Reduced Beclin 1 Diminishes Phagocytic Receptor Recycling
(A) To determine whether CD36 contributes to phagocytosis of latex beads, wild-type BV2 cells were cultured with latex beads in the presence or absence of
CD36 neutralizing antibody or IgG control antibody. Phagocytosis was quantified by flow cytometry.
(B–D) Using an established receptor recycling assay, CD36 receptor recycling was analyzed in BV2 cells infected with lentivirus encoding luciferase shRNA
(control) or beclin 1 shRNA (KD). Scale bar, 100 mm.
(E and F) CD36 receptor recycling was analyzed in Becn1+/ and WT primary microglia. The cell highlighted within the dashed box (E) is shown at a higher
magnification in the insert. Scale bar, 100 mm.
(G) Using flow cytometry, surface expression of CD36 was determined in the absence of ligand for BV2 cells infected with beclin 1 shRNA or control lentivirus.
(H) Trem2 receptor recycling was analyzed in BV2 cells infected with beclin 1 shRNA or control lentivirus. All bars are mean ± SEM; mean differences were
compared by a one-way ANOVA with a Tukey’s post test (A) or an unpaired Student’s t test (D and F–H). (A), (D), and (G), n = 3 per group; (F) and (H), n = 4–6 per
group. *p < 0.05, **p < 0.01; n.s., not significant.
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2010). This conserved structure is responsible for endosome-
to-Golgi retrograde transport of membrane proteins and in
mammals consists of the subunits Vps26, Vps29, Vps35, and
sorting nexins (Bonifacino and Hurley, 2008). To determine
whether beclin 1 might regulate the retromer complex, we
knocked down beclin 1 expression using a lentivirus encoding
beclin 1 shRNA and subsequently investigated whether the ret-
romer complex was affected by beclin 1 knockdown. Remark-
ably, beclin 1 knockdown resulted in a prominent reduction of
the retromer complex (Figures 4A and 4B). To test whether
diminished retromer expression impairs CD36 recycling, we
knocked down Vps35 levels in BV2 cells using lentivirus en-
coding Vps35 shRNA (Figure 4C) and analyzed CD36 recy-
cling. Reducing Vps35 significantly impaired CD36 recycling876 Neuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc.(Figure 4D). Furthermore, reducing Vps35 also resulted in a
concomitant reduction in phagocytic efficiency (Figure 4E).
Because previous studies have demonstrated that retromer
dysfunction can be reversed by enhancing Vps35 levels
(MacLeod et al., 2013), we rescued Vps35 levels in beclin
1-deficient BV2 cells. Rescuing Vps35 resulted in enhanced
CD36 recycling (Figure 4G) and phagocytosis (Figure 4H).
Together these data suggest that beclin 1 regulates the retro-
mer complex, which is required to maintain phagocytic receptor
recycling and phagocytosis.
To further explore this connection, we first tested whether
beclin 1 might regulate retromer via a direct interaction. This
proved unlikely, as we were unable to coimmunoprecipitate
beclin 1 and Vps35 (data not shown). Moreover, a recent study
using mass spectrometry screens to identify putative binding
Figure 4. Beclin 1 Regulates the Retromer
Complex, which Controls CD36 Recycling
(A and B) BV2 cells were infected with a lentivirus
encoding for luciferase shRNA (control) or beclin 1
shRNA (KD), and cell lysates were analyzed by
western blot to detect levels of the retromer
complex.
(C) BV2 cells were infected with a lentivirus en-
coding for Vps35 shRNA (Vps35 KD) or luciferase
shRNA (control), and cell lysates were probed by
western blot.
(D and E) CD36 receptor recycling (D) and
phagocytic efficiency (E) were then analyzed in
BV2 cells infected with Vps35 shRNA or control
lentivirus.
(F) To confirm our Vps35 rescue approach, HEK
cells were either infected with control lentivirus,
infected with beclin 1 shRNA lentivirus (Becn KD)
and transfected with a control RFP plasmid (Ctrl),
or infected with beclin 1 shRNA lentivirus and
transfected with a Vps35-T2A-RFP plasmid
(Vps35), and cell lysates were analyzed bywestern
blot.
(G and H) CD36 receptor recycling (G) and
phagocytosis (H) were impaired in BV2 cells in-
fected with beclin 1 shRNA lentivirus and trans-
fected with control plasmid when compared to
BV2 cells infected with beclin 1 shRNA lentivirus
and transfected with Vps35 plasmid. Phagocytic
analysis by flow cytometry was investigated in
cellular populations expressing RFP. All bars are
mean ± SEM and are representative of at least two
independent experiments (n = 3 per group). Mean
differences were compared by an unpaired Stu-
dent’s t test. *p < 0.05, **p < 0.01, ***p < 0.001.
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proteins that complex with beclin 1 did not reveal any binding
partners exclusive to the retromer complex (Behrends et al.,
2010). Therefore, we next tested whether beclin 1 may have a
role in the recruitment of retromer.
Retromer is typically recruited to vesicles via its sorting nexin
subunits. These subunits contain a Phox homology domain
capable of binding to phosphatidylinositol 3-phosphate (PI3P)
present on target membranes (Burda et al., 2002). Interestingly,
phosphatidylinositol is converted to PI3P primarily by the PI3K,
Vps34, which is known to form a complex with beclin 1 and
regulate autophagy and apoptosis (Funderburk et al., 2010). If
the beclin 1/Vps34 complex were responsible for recruiting ret-
romer in microglia, we speculated that reducing beclin 1 would
diminish Vps34 levels. Consistent with our previous observa-
tions in neurons (Jaeger et al., 2010), beclin 1 knockdown in
BV2 cells also resulted in a prominent reduction in Vps34 (Fig-
ure 5A). To begin to establish whether PI3P has a role in recruit-
ing retromer in BV2 cells, we next tested whether Vps35
colocalized with vesicles containing PI3P. To visualize PI3P
we utilized a reporter construct expressing an RFP fusion pro-
tein containing a 2xFYVE PI3P binding domain. Using this
approach, we observed colocalization of PI3P and Vps35 in
BV2 cells (Figure 5B). To determine the kinetics by which PI3P
and Vps35 localize to vesicles, we utilized live-cell imaging. Tobest monitor the recruitment of PI3P and Vps35 to clearly
defined vesicles, we provided latex beads to BV2 cells express-
ing either the PI3P reporter construct or a Vps35-RFP fusion
construct. These cells allowed us to track the uptake of latex
beads into clearly defined phagosomes. Given that the phago-
cytic receptor CD36 is involved in part in phagocytosing latex
beads (Figure 3A), and that beclin 1 and Vps35 play a role in
recycling CD36 (Figures 3 and 4), the phagosomal membrane
surrounding latex beads provides an excellent substrate to
monitor PI3P and Vps35 recruitment. Using this paradigm, we
find that PI3P is rapidly generated at the phagosomal mem-
brane within 10 min and is followed by the recruitment of
Vps35 around 20 min (Figure 5C).
To investigate the role of beclin 1 in these events, we knocked
down beclin 1 and monitored PI3P generation and Vps35
recruitment. In agreement with beclin 1 deficiency causing
diminished Vps34 levels (Figure 5A), reducing beclin 1 also
impaired the generation of PI3P at the phagosomal membrane
(Figure 5D; Movies S1 and S2) and the recruitment of Vps35
to the phagosomal membrane (Figure 5E; Movies S3 and S4).
Importantly, when Vps34 was inhibited with the PI3K inhibitor
3-methyladenine, which selectively inhibits Vps34 kinase activ-
ity (Miller et al., 2010), we observed mislocalization of Vps35
(Figure 5F) and reduced retromer complex levels (Figure 5G),
similar to what was seen in beclin 1 knockdown cells. TreatmentNeuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc. 877
Figure 5. Reduced Beclin 1 Impairs Vps34-Mediated Recruitment of Retromer
(A) Cell lysates from BV2 cells infected with lentivirus encoding for luciferase shRNA (control) or beclin 1 shRNA (KD) were analyzed by western blot.
(B) BV2 cells transfected with a phosphatidylinositol 3-phosphate (PI3P) reporter (2xFYVE-RFP) were immunofluorescently labeled for Vps35, and colocalization
was visualized by confocal microscopy. Arrows indicate vesicles with colocalization. Scale bar, 20 mm.
(C) Live-cell imaging of BV2 cells transfected with 2xFYVE-RFP or Vps35-RFP were used to monitor the kinetics by which PI3P and Vps35 localize to the
phagosomal membrane of internalized 6 mm latex beads.
(D and E) BV2 cells transfected with either 2xFYVE-RFP or Vps35-RFP were subsequently infected with beclin 1 or control shRNA lentivirus, and the phagosomal
localization of PI3P (D) and Vps35 (E) was similarly monitored by live-cell imaging after the internalization of 6 mm latex beads. The X symbols in (D) and (E)
represent the absence of localization in a 90 min live-cell imaging session. Please see Movies S1, S2, S3, and S4 for representative examples of phagosomal
localization.
(F) BV2 cells transfected with Vps35-RFP were treated with 10 mM of the PI3K inhibitor 3-methyladenine (3MA) or PBS (control) for 3 hr, and the localization of
Vps35 was visualized.
(G) Cell lysates from BV2 cells treated with 5 mM 3MA for 48 hr were probed by western blot to detect levels of the retromer complex.
(H) The average number of beads phagocytosed by BV2 cells receiving 10 mM 3MA or PBS (control) was quantified by flow cytometry. Values are mean ± SEM
and are representative of at least two independent experiments (C–E, n = 25–31 beads per group; H, n = 3 per group).
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Beclin 1 Regulates Phagocytic Efficiencywith 3-methyladenine also resulted in a significant impairment
in phagocytic efficiency that was similar to what was seen in
beclin 1 knockdown cells (Figure 5H). Given the role of PI3P in
regulating phagosomal maturation (Vieira et al., 2001), we
tested whether beclin 1-deficient BV2 cells show impairments
in phagosomal maturation. Indeed, beclin 1-deficient BV2 cells
also demonstrated impairments in phagosomal maturation (Fig-
ure S3). Together, these data indicate that beclin 1 works in
collaboration with Vps34 to generate PI3P at phagosomal mem-
branes, which then allows for the recruitment of the retromer
complex. When this process is disrupted, phagocytic receptor878 Neuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc.recycling, phagocytic efficiency, and phagosomal maturation
are impaired.
Reduced Microglial Beclin 1 Impairs Ab Phagocytosis
Given that beclin 1 deficiency impairs the recycling of CD36, a
known Ab phagocytic receptor, we next asked whether phago-
cytosis of Ab is impaired in beclin 1-deficient BV2 cells. To eval-
uate Ab phagocytosis, we used a previously described ex vivo
brain slice assay (Bard et al., 2000) (Figure 6A), where microglial
cells are added to unfixed brain slices from aged, plaque-depos-
iting APP transgenic mice. Microglia then surround and engulf
Figure 6. Reduced Microglial Beclin 1 Impairs Ab Phagocytosis
(A) BV2 cells were infected with beclin 1 shRNA (KD) or luciferase shRNA (control) lentivirus and cultured on 10 mm thick freshly cut, unfixed brain slices from APP
transgenic mice. After 24 hr the slices were processed for Ab histology or ELISA.
(B) Confocal microscopy confirmed that BV2 cells cultured on APP brain slices contained Ab after 24 hr of culture. Transduced BV2 cells were visualizedwith GFP
and Ab was visualized with 3D6. Scale bar, 10 mm.
(C–E) Sections were then probed for Ab (C), and Ab load was quantified in the hippocampus (D) and cortex (E). Scale bar, 200 mm.
(F and G) Ab was also extracted from replicate slices and total Ab (F) and Ab1-42 (G) were measured by ELISA. Please see Figure S4 for analysis with primary
microglia. All bars are mean ± SEM. Mean differences were compared by a one-way ANOVA with a Tukey’s post test (D and E) or an unpaired Student’s t test
(F and G) and are representative of at least two independent experiments (n = 6–10 per group). *p < 0.05.
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Beclin 1 Regulates Phagocytic EfficiencyAb (Figure 6B), and its removal can be measured immunohisto-
chemically or by ELISA. While control BV2 cells efficiently
cleared Ab deposits from these brain sections, beclin 1-deficient
cells were significantly less efficient at clearing the aggregates
in both the hippocampus (Figures 6C and 6D) and cortex (Fig-
ure 6E). These histological findings were supported by indepen-
dent measurements of Ab content in brain slices by ELISA
(Figures 6F and 6G). Moreover, primary microglia isolated from
beclin 1+/mice showed similar impairments in Ab phagocytosis
when compared to wild-type littermates (Figures S4A and S4B).
Importantly, Ab phagocytosis by beclin 1-deficient BV2 cells
could be rescued by recovering beclin 1 levels (Figures S4C
and S4D).
To determine whether beclin 1 has a role in the removal of
extracellular Ab in vivo, we used beclin 1+/ mice and injected
fibrillar Ab into the frontal cortex (Figure 7A). In agreement with
our ex vivo phagocytosis assay, the removal of Ab was signifi-cantly impaired in beclin 1-deficient mice, resulting in twice as
much Ab remaining in the brains of beclin 1+/ mice compared
with wild-type littermates (Figures 7B and 7C). We then tested
whether reduced phagocytic capacity could explain impair-
ments in the removal of Ab in vivo by injecting pH-sensitive
beads, which fluoresce when internalized by microglial cells
(insert of Figure 7D), into the frontal cortex of beclin 1+/ mice
or wild-type littermates. Quantification of fluorescence as an
indicator of phagocytosed beads showed that beclin 1+/ mice
phagocytosed almost 4-fold fewer beads than wild-type mice
(Figures 7D and 7E). Because the fluorescence readout of our
pH-sensitive beads could be confounded by changes in phago-
somal or lysosomal pH, we tested whether reduced beclin 1
levels might affect phagosomal or lysosomal pH. To do this,
we isolated primary microglia from beclin 1+/ mice and
analyzed lysosomal pH in these cells using LysoSensor Yellow/
Blue dextran (Lee et al., 2010) (Figure 7F). In addition, weNeuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc. 879
Figure 7. Beclin 1-Deficient Mice Demonstrate Impaired Extracellular Ab Clearance and Phagocytosis
(A) To determine whether beclin 1+/ mice (Becn1+/) demonstrate deficits in extracellular Ab phagocytosis and removal, fibrillar Ab1–42 or pH-sensitive beads
were stereotaxically injected into the frontal cortex. Brain image was obtained from Allen Brain Atlas.
(B and C) Residual Ab was quantified histologically 48 hr after injection. Scale bar, 500 mm.
(D and E) Fluorescence from pH-sensitive beads, which was confirmed with BV2 cells in vitro (see insert), was quantified from confocal images 48 hr after
injection. Scale bar, 200 mm.
(F) Primary microglia isolated from beclin 1+/mice were analyzed by LysoSensor Yellow/Blue dextran to determine relative lysosomal pH levels. For additional
measures of phagosomal and lysosomal pH, please see Figure S5. Results were analyzed by an unpaired Student’s t test (n = 9–11 (C) and (E) or n = 4 (F) per
group). All values are mean ± SEM. *p < 0.05; n.s., not significant.
Neuron
Beclin 1 Regulates Phagocytic Efficiencyanalyzed phagosomal and lysosomal pH using FITC-conjugated
beads (Figure S5). Phagosomal and lysosomal pH in beclin
1-deficient cells were not significantly different than control cells
(Figure 7F; Figure S5), suggesting that the diminished fluores-
cent signal in beclin 1+/ mice injected with pH-sensitive beads
is likely due to reduced uptake of the pH-sensitive beads.
Together, these ex vivo and in vivo studies support our cell
culture experiments and demonstrate that beclin 1 is necessary
for efficient phagocytosis.
Microglia fromHumanADBrains Exhibit ReducedBeclin
1 and Retromer
While our studies point to a key role for beclin 1 in regulating
retromer function and phagocytosis in vitro and in vivo (using
mouse models), we next asked whether our findings might be
clinically relevant for human disease. Indeed, previous studies
have demonstrated that beclin 1 protein levels are reduced in
AD brain lysates (Crews et al., 2010; Jaeger et al., 2010; Pickford
et al., 2008) and that retromer mRNA is selectively decreased in
entorhinal cortex versus the dentate gyrus of AD patients (Small
et al., 2005). However, beclin 1 and retromer levels in AD micro-
glia are unknown. To determine whether beclin 1 and retromer880 Neuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc.are reduced in AD brains and in microglia in particular, we
analyzed brain lysates from themidfrontal gyrus, andwe isolated
microglia from superior andmiddle frontal gyri of postmortemAD
and nondemented control brains. We discovered that Vps35
levels were reduced by roughly half in brain homogenates from
beclin 1+/ mice and AD patients (Figure S6). Importantly, we
find that microglia obtained from AD brains have prominently
reduced levels of beclin 1 and VPS35 (Figures 8A and 8B)
when compared to nondemented controls. However, neither
beclin 1 nor Vps35 levels were reduced in brain lysates from
plaque-depositing 16-month-old APP transgenic mice (Fig-
ure S7). Collectively, these findings suggest that beclin 1 is
reduced in microglia within AD brains and that this deficiency
is not the result of amyloid accumulation alone but may have
other causes.
DISCUSSION
In this study, we define a function for the autophagy protein
beclin 1 in regulating phagocytosis and phagocytic receptor
recycling. Importantly, our observations appear to be clinically
relevant as microglia isolated from human AD postmortem
Figure 8. Microglia Isolated from Human
AD Brains Show Reduced Levels of Beclin
1 and VPS35
(A and B) Human microglia isolated from the
superior and middle frontal gyri of postmortem
AD or nondemented control patients were
lysed, the detergent soluble protein fraction was
probed by western blot (A), and protein levels
were quantified relative to actin (B). Results
were analyzed by an unpaired Student’s t test
(n = 5 per group). All values are mean ± SEM.
***p < 0.001.
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findings open the possibility that reduced microglial beclin 1
levels in AD patients impair phagocytic capacity when
compared to microglia from healthy controls (Figure S8). Inde-
pendent studies are in line with this notion and show that
microglia in mouse models of AD are inefficient at phagocy-
tosing and clearing Ab (Meyer-Luehmann et al., 2008). Whether
‘‘healthy’’ microglia are active participants in controlling Ab
levels remains controversial (Grathwohl et al., 2009). In spite
of this uncertainty, numerous studies show that activating
microglia with either lipopolysaccharide (Herber et al., 2004),
genetic manipulation (Heneka et al., 2013; Liu et al., 2010;
Town et al., 2008; Wyss-Coray et al., 2001), or following Ab
vaccination (Bard et al., 2000) is sufficient to promote removal
of Ab in vivo. Emerging evidence supports the idea that micro-
glial phagocytosis may have important roles in AD progression.
This is indicated by genetic studies showing that variants of the
phagocytic receptor TREM2 triple the risk for AD (Guerreiro
et al., 2013; Jonsson et al., 2013). While the mechanisms
underlying this risk are unclear, it is postulated that microglia
may play an active role in removing Ab, apoptotic cellular, or
synaptic debris and in the process prevent the activation of
rampant inflammation during AD. Taken together, microglial
phagocytosis may have multiple functions in the healthy and
diseased brain, which help to prevent amyloid accumulation
and clear cellular debris. Given that we find general defects
in phagocytosis when beclin 1 is reduced (i.e., with latex
beads and Ab), it is possible that recovering beclin 1 and
phagocytic receptor recycling levels may be necessary for pro-
moting optimal and sustained phagocytosis of disease-relevant
substrates.
Additionally, our findings may also provide insight into phago-
cytic effectiveness beyond AD. For example, pathogens,
including HSV-1 and gammaherpesviruses, encode factors
that directly antagonize beclin 1 (Ku et al., 2008; Orvedahl
et al., 2007). This may represent a strategy to impair phagocy-
tosis and prevent viral clearance. Although inhibiting beclin 1
is likely to affect various cellular processes that could influence
substrate clearance, including autophagy and potentially phag-
osomal maturation (which has been described for phagosomes
containing apoptotic cells, entotic cells, and bacteria (Berger
et al., 2010; Florey et al., 2011; Ma et al., 2012; Martinez
et al., 2011), our studies further reveal that inhibiting beclin 1
may also cause impairments upstream at the receptor level to
disrupt phagocytic efficiency. One way that inhibiting beclin 1
might disrupt phagocytic efficiency is by impairing phagocyticreceptor recycling, as our studies on CD36 and Trem2 recycling
indicate.
If the mechanisms described here for CD36 and Trem2 recy-
cling are usedmore widely, it is tempting to speculate that beclin
1 deficiency might also result in dysfunctional turnover and
availability of other membrane receptors. Notably, receptors
for various growth factors or NMDA are dysregulated in AD (Iko-
nomovic et al., 1999; Moloney et al., 2010; Tesseur et al., 2006).
Additionally, beclin 1 has been shown to be associated with
several surface receptors, including delta 2 glutamate receptors
(Yue et al., 2002) and bacterial SLAM receptors (Berger et al.,
2010; Ma et al., 2012). It is currently unclear if beclin 1 is involved
in the regulation and trafficking of these or any other receptors.
Intriguingly, studies in C. elegans reveal a conserved role for
beclin 1 in regulating Wnt receptor recycling. Indeed,
C. elegans expressing a mutant form of BEC-1, the C. elegans
ortholog of beclin 1, display defective recycling of theWnt recep-
tor MIG-14/Wntless, a receptor that is classically recycled by the
retromer complex. Moreover, BEC-1 mutants exhibit reduced
levels of PI3P and the retromer subunit RME-8 (Ruck et al.,
2011). Our findings are in line with these observations, and
together they support the possibility that mechanisms described
herein may be applicable to other receptors that utilize retromer-
mediated recycling.
Given that retromer is involved in the sorting of various
disease-relevant proteins, beclin 1-mediated impairments in
retromer sorting could also play an important role in neurode-
generative disease. For example, both APP and b-secretase
are dependent on retromer trafficking (Andersen et al., 2005;
Finan et al., 2011; Wen et al., 2011). Additionally, the retromer-
binding receptor SorLA is reduced in AD and may disrupt APP
trafficking and subsequent processing (Andersen et al., 2005).
Most recently, genetic mutations in VPS35 have been linked to
autosomal dominant Parkinson’s disease in two independent
studies (Vilarin˜o-Gu¨ell et al., 2011; Zimprich et al., 2011),
suggesting retromer-mediated impairments in receptor recy-
cling or protein sorting might also play an important role in
Parkinson’s disease. It remains to be shown whether these
mutations or other retromer abnormalities lead to impaired
receptor recycling or phagocytosis. It is also unknown why
beclin 1 is changed in AD and in microglia. Nevertheless, if beclin
1 proves to be a critical upstream regulator of retromer function
in humans, restoring proper beclin 1 expression may have
beneficial effects on sustaining various retromer-mediated pro-
cesses in conditions where beclin 1 is disrupted or reduced. In
particular, restoring beclin 1 expression in AD may represent aNeuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc. 881
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removal of Ab aggregates.
EXPERIMENTAL PROCEDURES
Mice
T41 APP transgenic mice (mThy-1-hAPP751V171I, KM670/671NL) and beclin 1
+/
mice have been described previously (Pickford et al., 2008; Qu et al., 2003).
Beclin 1+/ mice were crossed with heterozygous T41 transgenic mice. All
lines were maintained on a C57BL/6 genetic background. Brains were har-
vested frommice anesthetized with 400mg/kg chloral hydrate (Sigma-Aldrich)
and transcardially perfused with 0.9% saline. Brains were then dissected, and
1 hemibrain was fixed for 24 hr in 4% paraformaldehyde and cryoprotected
in 30% sucrose. Serial coronal sections (30 or 50 mm) were cut with a freezing
microtome (Leica) and stored in cryoprotective medium. When possible,
the other hemibrain was frozen immediately at 80C for additional analyses.
All animal procedures were conducted with approval of the animal care
and use committees of the Veterans Administration Palo Alto Health Care
System.
Antibodies for Immunohistochemistry and Immunoblotting
The following antibodies were used: 3D6 (1:8,000; Elan Pharmaceuticals),
which was biotinylated using EZ-link NHS Biotin (Pierce Biotechnology); actin
(diluted 1:5,000; Sigma-Aldrich); Atg5 (diluted 1:500; Novus Biologicals);
beclin 1 (diluted 1:500; BD Biosciences); CD36 (Abcam; [JC63.1] for receptor
recycling assays and [FA6-152] for neutralization); CD68 (diluted 1:50; Sero-
tec); EEA1 (Abcam); Iba-1 (diluted 1:2,500; Wako Bioproducts); Lamp1
(Abcam); NSE (LabVision); Rab5 (Sigma); Rab7 (Cell Signaling); Trem2 (R&D
Systems); Vps26 (diluted 1:500; Abcam); Vps29 (diluted 1:500; Abcam);
Vps34 (diluted 1:200; Invitrogen); and Vps35 (diluted 1:500; Abcam).
Viral Infection
BV2 and N9 microglial cells were maintained in DMEM media containing
10% FBS. Cells were transduced with lentivirus (LV) containing an shRNA
plasmid targeting mouse beclin 1 at nucleotides 405–423, which also
expressed a copoped GFP. LV targeting Atg5 contained an shRNA plasmid
targeting nucleotides 302–320 of the mouse Atg5 transcript. LV targeting
Vps35 consisted of a mixture of three separate LVs, each containing a
19–25 nucleotide shRNA sequence targeting a different region of the mouse
Vps35 transcript. Control LV contained the same plasmid backbone, but ex-
pressed an shRNA sequence targeting luciferase. For beclin 1 rescue exper-
iments, LV particles contained a plasmid encoding mouse beclin 1. Cells
were infected in 96-well plates at a multiplicity of infection of 50 or 100 in
the presence of polybrene (8 mg/ml). Eighteen hours after infection, virus-
containing media were removed and replaced with normal maintenance
media. Twenty-four hours later, cells were split into 24-well plates. Twenty-
four hours later (72 hr after infection), cells were used in phagocytosis and
receptor recycling assays. At 72 hr posttransduction, our lentiviral constructs
were well tolerated, with nearly 95% viability as measured by trypan blue
exclusion (data not shown). When used in ex vivo phagocytosis assays,
BV2 cells were transferred to 10 cm dishes and grown until confluent.
When possible, successful transduction was monitored by GFP expression
and confirmed by western blot. Vps35 shRNA LV particles were purchased
from Santa Cruz Biotechnology. All other LV plasmids were prepared as pre-
viously described (Marr et al., 2003) and generated by the Stanford Neurosci-
ence Gene Vector and Virus Core.
Western Blotting
All tissues or cells were lysed in RIPA buffer, and total protein concentrations
were determined with a BCA Protein Assay Kit (Thermo Scientific). Total pro-
tein (10–20 mg) was loaded for each sample into precast 4%–12% bis-tris gels
and run with MOPS buffer (Invitrogen). Gels were transferred onto PVDF
membranes (Millipore). Antigen-specific primary antibodies were incubated
overnight at 4C and detected with species-specific horseradish-peroxi-
dase-labeled secondary antibodies. An ECL Western Blotting Detection kit
(GE Healthcare) was used to obtain a chemiluminescence signal, which882 Neuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc.was detected using Amersham Hyperfilm ECL (GE Healthcare). Band quanti-
fication was performed using ImageJ software (version 1.44; NIH). Bands of
interest were normalized to actin- or neuron-specific enolase for a loading
control.
Isolation of Primary Mouse Microglia
Beclin 1+/ and wild-type littermate pups were sacrificed at postnatal day 6–8.
Brains were dissected from the pups, the meninges were removed, and the
cortex was isolated. Cortical tissue was then dissociated into single cells using
the Neural Tissue Dissociation Kit P (Miltenyi Biotec). Cells were washed with
Hank’s Balanced Salt Solution and resuspended in PBS containing 0.5%
bovine serum albumin and 2 mM EDTA (MACS buffer). To positively select
for microglia, 10 ml of CD11b MicroBeads (Miltenyi Biotec) were added per
107 total cells. Cells were then washed with MACS buffer and applied to a
LS separation column placed in a magnetic holder (Miltenyi Biotec). Unlabeled
cells were allowed to pass through the column while labeled cells remained in
the magnetic field. After washing the column with MACS buffer, the column
was removed from the magnetic field and the labeled cells were flushed
from the column with MACS buffer. The resultant cell population, which was
confirmed by flow cytometry to be 90% pure for microglia (Figure 2C), was
then cultured in DMEM:F12 with 10% FBS for at least 3 days before being
used for functional studies.
Phagocytosis Assay
BV2 cells were plated in 24-well plates at a density of 30,000 cells per well in
DMEMwith 10% FBS. Cells were cultured at 37C for 1 hr. Latex beads (6 mm,
internally dyed with the fluorophore Flash Red; Polysciences, Inc.) were pre-
opsonized in 50% FBS and PBS. BV2 cell media was then replaced with
DMEM alone, and preopsonized beads were added to the cells at a concen-
tration of ten beads per cell. BV2 cells and beads were incubated at 37C
for 1 hr and were subsequently transferred to 5 ml polystyrene fluorescence-
activated cell sorting (FACS) tubes with the aid of 0.25% trypsin. Cells
were centrifuged at 1,200 rpm for 5 min and washed twice with cold FACS
buffer, consisting of 1% FBS and 0.02% sodium azide in PBS. Cells were
resuspended in FACS buffer and analyzed by flow cytometry, as described
below.
Flow Cytometry
All flow cytometry experiments were performed on an LSR-II FACS machine
(BD Biosciences). For phagocytosis assays, events were thresholded for
size as to exclude the visualization of free latex beads. At least 2,500 events
were recorded for each sample. CD36 surface expression was assayed on
fixed, unpermeablized cells using a phycoerythrin-tagged CD36 antibody
(BioLegend). At least 25,000 events were recorded for each sample. Analysis
was performed using FlowJo (version 9.2; Tree Star Inc.).
Live-Cell Phagocytosis Imaging
BV2 cells were transduced with lentivirus encoding either beclin 1 shRNA or
luciferase shRNA control. Both lentiviruses also expressed a copoped GFP
to allow for the visualization of infected cells. Forty-eight hours after lentiviral
transduction, beclin 1 shRNA and luciferase shRNA control cells were plated
in separate chambers of 2-well chamber slides and incubated for 1 hr at
37C in DMEM with 5 ng/ml GM-CSF. Polystyrene beads (Polysciences,
Inc.) preopsonized in 50% FBS were added at a concentration of five beads
per cell immediately before imaging. Several fields from eachwell were imaged
on a Zeiss Observer.Z1 inverted microscope. Cells were kept at 37C and 5%
CO2 with a Zeiss XL S1 stage incubator. Phase and GFP images were
collected every 5 min for 2 hr using Axiovision 4.7.1 software (Zeiss) and
exported as individual JPEG files. Individual frames were compiled and
analyzed in ImageJ. Images from three independent experiments were blinded
and only GFP-positive cells (n = 15) in each condition were analyzed. The num-
ber of beads in each cell was counted for every frame. A bead was considered
cell associated when at least half of the bead was within the cell’s perimeter
and stayed associated for the remainder of the movie. Cell movement was
analyzed with ImageJ using the MTrackJ plug-in. Live-cell imaging for phago-
somal PI3P, phagosomal Vps35, or intracellular pH analysis with FITC beads
was performed with a LSM 700 confocal microscope (Zeiss) using Zen 2010
Neuron
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imaged every 5 min for 30–90 min.
Receptor Recycling Assay
Receptor recycling assays were performed as previously described (Mitchell
et al., 2004). Briefly, BV2 cells were plated on poly-L-lysine-coated glass
coverslips in 24-well plates at a density of 70,000 cells per well. Cells were
maintained in DMEM with 10% FBS for 48 hr. Cells were then incubated in
DMEM with 10% donkey serum (the source of the secondary antibody) for
15 min at 37C. Antibodies against CD36 (Abcam) or Trem2 (R&D Systems)
were added to the cells in DMEM with 1% donkey serum for 1 hr at 37C.
Cells were then acid washed with cold DMEM at pH 2.0. Cells were cultured
in DMEM with 10% donkey serum for 1 hr at 37C and then provided fluoro-
phore-conjugated secondary antibodies (Alexa Fluor 555 or Alexa Fluor 647
for Vps35 rescue experiments; Invitrogen) in 1% donkey serum for 1 hr at
37C. Cells were again acid washed with cold DMEM at pH 2.0 and washed
with cold PBS. Cells were then fixed with 4% paraformaldehyde, washed
with PBS, and mounted on glass slides using Prolong Gold (Invitrogen). Fluo-
rescent signal from vesicles containing recycled receptors was thresholded,
and the area of fluorescent signal was determined by ImageJ. The area of
fluorescent signal was then divided by the total number of cells present in
the field to generate a measurement of fluorescent area per cell. For all
experiments, investigators were blinded with respect to the treatment
condition.
Cloning of Vps35 Plasmids
Mouse wild-type Vps35 cDNA was purchased (Origene), and the full-length
cDNA was cloned into the ligase-free cloning site of the pPS-EF1-LCS-T2A-
RFP lentiviral vector (System Biosciences), which coexpresses RFP. To
generate a Vps35-RFP fusion construct, the T2A domain of the plasmid
described above was deleted using a QuikChange site-directed mutagenesis
kit (Agilent Technologies) with the following primer: CTGTTCGAGAGGG
CAGAGGAGAATTCATGGCCCTTAGTAAGC.
Transfection of BV2 Cells by Electroporation
BV2 cells were transiently transfected by electroporation as previously
described (Smale, 2010). Briefly, cells were resuspended in DMEM media
containing 10% FBS at a concentration of 3.75 3 107 cells/ml. Two hundred
microliters of cells and 20 mg of plasmid DNA were transferred to Gene Pulser
cuvettes with a 0.4 cm electrode gap (Bio-Rad). A 250 V charge was applied to
each cuvette using a Gene Pulser II electroporation system with a 950 mF
capacitor (Bio-Rad). Transfected cells were plated in DMEMmedia containing
10% FBS and utilized 48 hr later.
Ex Vivo Ab Phagocytosis Assay
Ex vivo Ab phagocytosis assays were performed as previously described
(Bard et al., 2000). Briefly, 18-month-old T41 transgenic mice were perfused
with saline. Brains were removed and snap-frozen in cooled isopentane.
Frozen brains were cut into 10 mm thick sagittal sections using a cryostat
(Leica) and mounted onto poly-L-lysine-coated glass coverslips. Brain sec-
tions were allowed to dry for at least 2 hr at room temperature and then
washed with hybridoma serum-free media (H-SFM; Invitrogen) containing
1% FBS. Brain sections were then cultured with 5 3 105 BV2 cells in
H-SFM containing 1% FBS for 18 hr at 37C with 5% CO2 or 1.75 3 10
5 pri-
mary mouse microglial cells in H-SFM containing 1% FBS and 5 ng/ml
GM-CSF (R&D Systems) for 60 hr at 37C with 5% CO2. Sections were
then washed twice with PBS and either fixed with 4% paraformaldehyde
for subsequent histology or placed in 6.25 M guanidinhydrochloride to extract
Ab for ELISAs (see below).
Ab ELISA
Enzyme-linked immunosorbent assays were performed using Meso Scale
technology (Meso Scale Discovery). Multiarray 96-well plates (Meso Scale Dis-
covery) were coated with capture antibody 21D12 for total Ab (Ab13–28) or anti-
body 21F12 for Ab42 (Ab33–42). Plates were washed and diluted samples and
Ab standards were added. Ab was detected using biotinylated-3D6 antibody
(Ab1–5) and SULFO-TAG streptavidin (Meso Scale Discovery). Plates wereread on a Sector Imager 2400 (Meso Scale Discovery) and samples
were normalized to Ab standards. All Ab antibodies were provided by Elan
Pharmaceuticals.
In Vivo Phagocytosis Assays
Fibrillar Ab1–42 was prepared by incubating synthetic monomers, diluted to a
stock concentration of 1 mg/ml in PBS, overnight at 37C. pH-sensitive beads
were prepared by coupling 3 mm latex beads with CypHer5E mono N-hydrox-
ysuccinimide (NHS) ester (GE Healthcare). Beads were washed extensively
and diluted in PBS to a stock concentration of 2 3 104 beads/ml. Eight-
week-old mice were then anesthetized with an inhaled isoflurane/oxygen
mixture and 1 ml Ab or pH-sensitive beads were stereotaxically injected into
the frontal cortex using the following coordinates from bregma: +1.9 mm
anterior, +1.5 mm lateral, and a depth of 1 mm with an injection speed of
0.2 ml/min. Forty-eight hours later, mice were perfused as described above
and brains were prepared for histological analysis.
Histology
Fixed sections were permeabilized with 0.1%Triton X-100 and 0.6%hydrogen
peroxide. For Ab histology, sections were blocked using a streptavidin and
biotin blocking kit (Vector), and biotinylated 3D6 antibody was applied
(1:8,000) overnight at 4C. Primary antibody labeling was revealed using
ABC kit (Vector) with diaminobenzidine (DAB; Sigma-Aldrich). For fluorescent
double-immunolabeling, Iba-1 and 3D6 primary antibodies were detected with
fluorophore-conjugated secondary antibodies (Alexa Fluor 488 and 555,
respectively; Invitrogen). For studies with beclin 1+/ mice, coronal sections
were cut at 50 mm for in vivo pH bead analysis using a freezing microtome
(Leica). All sections with the appearance of a needle track were selected,
and pH-sensitive beads could be observed with confocal microscopy without
histological procedures. Sections stained for Ab were imaged with a Cool-
SNAP HQ camera (Photometrics) mounted on an Olympus IX71 microscope
(Olympus America, Inc.) using Spot Software (version 4.7; Diagnostic Instru-
ments, Inc.). For ex vivo phagocytosis sections, digitized images were thresh-
olded for positive Ab labeling and percent thresholded area was determined
withMetamorph (Molecular Devices Corporation). For pH-sensitive bead anal-
ysis, 6 mm thick optical z stack slices were generated with Zeiss software
(version 4.2) for all sections where beads were visible. The total area of bead
fluorescence in all slices from sections with positive signal was determined
with ImageJ. For all experiments investigators were blinded with respect to
the genotype of the mice or treatment condition.
Isolation of Human Microglia
Microglia were isolated from postmortem AD-confirmed or nondemented,
nonpathological control brains (see Table S1 for more details) as previously
described (Lue et al., 2001). Cells were then cultured in DMEM media supple-
mented with 10% FBS for 10–14 days at 37C with 7% CO2. Cells were iso-
lated from culture flasks with 0.25% trypsin and manual separation using a
cell scraper (Nunc) and prepared for flow cytometry or western blot analysis
as described above. Previous studies show that these cultures are 99%
pure by demonstrating positive CD68 immunoreactivity and negative immuno-
reactivity for glial fibrillary acidic protein and galactocerebroside (Lue et al.,
2001). Purity of microglial cultures was also confirmed in our studies using an-
tibodies against CD11b (BD Biosciences) as a marker for myeloid-derived
cells. Flow cytometric analysis confirmed that our cultures were greater than
80% positive for CD11b (data not shown).
Human Brain Tissue
Brain tissues from confirmed AD and age-matched, nondemented, non-
pathological controls (see Table S2 for more details) were obtained from
ADRC at the University of California San Diego, The Institute for Brain Aging
and Dementia Tissue Repository at the University of California Irvine, Stan-
ford Brain Bank at Stanford University, and The L.J. Roberts Alzheimer’s
Center at Banner Sun Health Research Institute in strict accordance with
all ethical and institutional guidelines. Cortical midfrontal gray matter tissues
were cut from frozen tissue blocks and subjected to protein extraction using
procedures described above. Microglia were isolated from cortical midfrontal
gray matter tissues at the Banner Sun Health Research Institute using freshNeuron 79, 873–886, September 4, 2013 ª2013 Elsevier Inc. 883
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0.55 hr.
Statistics
All statistical analyses were computed using Prism5 (GraphPad Software). Dif-
ferences between treatment conditions were established using a Student’s
unpaired t test (for two conditions), a one-way ANOVA with a Tukey’s post
test for multiple comparisons, or a two-way ANOVA with a Bonferroni post
test when comparing groups with multiple variables. p values of less than
0.05 were considered significant. Statistic details are indicated in the respec-
tive figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures, four movies, and two tables and can be found with this article
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